|
|
|||
| |||||||||||||||||||||||||||||||
Anyone bold enough to predict 50 years ago that by the coming turn of the century a substantial proportion of hematologic diseases, and some nonhematologic diseases, would be treated successfully by clinicians collecting marrow cells from one person and transfusing them into another admittedly with sophisticated ancillary maneuvers to prepare the patient and to continue support after he or she receives this "hematopoietic stem-cell transplant" would have encountered some incredulity, if not ridicule. But this, of course, is precisely what has happened in the past 40 years. Much of this remarkable progress is documented in encyclopedic detail in
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |